Apnimed's sleep apnea pill clears second Phase 3, setting up FDA filing

The first pill for obstructive sleep apnea is getting closer to market. Apnimed's AD109 has now passed the bar in its second Phase 3 study, the Cambridge, MA-based biotech said Wednesday morning. The results, which ...